This study is a prospective observer blinded, central randomization controlled, multi-center clinical trial to assess the relationship between intraoperative FiO2 and postoperative pulmonary complications with lung injury.
Hyperoxia is common in cardiac surgery and is easy to prevent by adjusting FiO2. Since there is no prospective study on different FiO2 and postoperative pulmonary complications (PPCs) during cardiac surgery. We hypothesized that hyperoxia during cardiac surgery could lead to higher incidence of lung injury and PPCs than normoxia. The objective of this trial is to compare postoperative PPCs and other outcomes between hyperoxia and normoxia strategy by PaO2/FiO2 in CABG patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Fraction of Inspired Oxygen during cardiac surgery, including cardiopulmonary bypass
Jewish Hospital
Louisville, Kentucky, United States
arterial PO2/FiO2 Ratio
minimal postoperative arterial PO2/FiO2 Ratio
Time frame: 48hr post operation
Pulmonary complications
ARDS, noncardiogenic pulmonary edema, pulmonary infection, pneumonia, pleural effusion, atelectasis, and respiratory failure are secondary endpoints
Time frame: up to one week while in the hospital
length of mechanical ventilation
time from skin closure to extubation
Time frame: up to one week while in the hospital
length of postoperative ICU stay
time from ICU entry to discharge from ICU
Time frame: up to one week while in the hospital
length of hospital stay
time from surgery day to discharge from ICU
Time frame: up to one week while in the hospital
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.